We observed that siRNA-mediated knockdown of SLC3A2 over time reduced the proliferation rate in CLB-BAR, CLB-GE and CLB-GAR ALK-addicted NB cell lines with two independent siRNAs targeting SLC3A2 (Fig. 3A). The gene discussed is ALK; the disease is neuroblastoma.